Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ACTRN12626001137381) titled 'Faecal Microbiota Transplantation Optimised Immune Checkpoint Inhibitor Therapy in Advanced Cutaneous Squamous Cell Carcinoma' on Sept. 11.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Parallel
Type of endpoint: Efficacy
Primary Sponsor: St Vincent's Hospital, Melbourne
Condition:
Advanced Cutaneous Squamous Cell Carcinoma
Advanced Cutaneous Squamous Cell Carcinoma
Cancer - Non melanoma skin cancer
Skin - Other skin conditions
Intervention:
Faecal Microbiota Transplant (FMT) Intervention
Participants receive t...